VisionCare expands CentraSight telescope implant provider teams
VisionCare Ophthalmic Technologies, Inc., developer of the first FDA-approved ophthalmic telescope implant indicated to improve vision in patients with end-stage age-related macular degeneration (AMD), announced today the expansion of its CentraSightâ„¢ provider teams nationwide.